Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
DelMar Pharmaceuticals goes public through reverse merger
18 Mar 2013
Cancer therapeutics developer DelMar Pharmaceuticals BC Ltd. has reverse merged with public shell company Berry Only Inc., which changed its name to DelMar Pharmaceuticals Inc. for the purpose of the acquisition. The new parent, DelMar Pharmaceuticals Inc., will trade on the OTC Bulletin Board under the symbol DMPI.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?